Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.71 | -$0.63 | -$0.67 |
| Q2 2026 | 2 | -$1.34 | -$0.61 | -$0.98 |
| Q3 2026 | 2 | -$2.15 | -$0.29 | -$1.10 |
| Q4 2026 | 1 | -$1.19 | -$1.19 | -$1.19 |
| Q1 2027 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q2 2027 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q3 2027 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2027 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q1 2028 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2028 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2028 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q4 2028 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q1 2029 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2029 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2029 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q4 2029 | 1 | -$0.30 | -$0.30 | -$0.30 |
ImageneBio Inc. last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.95 earnings per share for the quarter, missing analysts' consensus estimates of $-0.7 by $0.25. The company had revenue of 0 for the quarter and had revenue of 800.00 K for the year. ImageneBio Inc. has generated $-11 earnings per share over the last year ($-10.76 diluted earnings per share) and currently has a price-to-earnings ratio of -1.45. ImageneBio Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.70 | -$0.95 | -0.25 | $0 | $0 |
| 03/10/2026 | Q4 2025 | -$1.45 | -$0.62 | 0.83 | $0 | $0 |
| 11/12/2025 | Q3 2025 | -$1.47 | -$3.01 | -1.54 | $0 | $0 |
| 07/24/2025 | Q2 2025 | -$0.14 | -$0.06 | 0.08 | N/A | $0 |
| 05/08/2025 | Q1 2025 | -$0.21 | -$0.18 | 0.03 | N/A | $0 |
| 03/06/2025 | Q4 2024 | -$0.19 | -$0.19 | 0 | $875.00 K | $0 |
| 11/07/2024 | Q3 2024 | -$0.27 | -$0.21 | 0.06 | N/A | $0 |
| 08/08/2024 | Q2 2024 | -$0.31 | -$0.28 | 0.03 | N/A | $0 |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.33 | 0.07 | $2.33 M | $0 |
| 03/12/2024 | Q4 2023 | -$0.41 | -$0.41 | 0 | N/A | $659.00 K |
| 11/09/2023 | Q3 2023 | -$0.44 | -$0.40 | 0.04 | N/A | $1.19 M |
| 09/12/2023 | Q2 2023 | N/A | -$0.43 | N/A | N/A | $2.00 M |
| 05/15/2023 | Q1 2023 | -$0.46 | -$0.39 | 0.07 | N/A | $5.31 M |
| 03/14/2023 | Q4 2022 | -$0.53 | -$0.36 | 0.17 | N/A | $5.45 M |
| 11/07/2022 | Q3 2022 | -$0.50 | -$0.46 | 0.04 | N/A | $6.40 M |
| 08/11/2022 | Q2 2022 | -$0.48 | -$0.55 | -0.07 | N/A | $382.00 K |
| 05/12/2022 | Q1 2022 | -$0.42 | -$0.46 | -0.04 | N/A | $3.38 M |
| 03/17/2022 | Q4 2021 | -$0.51 | $0.08 | 0.59 | N/A | $20.22 M |
| 11/10/2021 | Q3 2021 | -$0.41 | -$0.40 | 0.01 | N/A | $3.75 M |
| 08/12/2021 | Q2 2021 | -$0.32 | -$0.35 | -0.03 | N/A | $3.55 M |
The conference call for ImageneBio Inc.'s latest earnings report can be listened to online.
The conference call transcript for ImageneBio Inc.'s latest earnings report can be read online.
ImageneBio Inc. (:IMA) has a recorded annual revenue of $800.00 K.
ImageneBio Inc. (:IMA) has a recorded net income of $-45,349,000.ImageneBio Inc. has generated $-10.76 earnings per share over the last four quarters.
ImageneBio Inc. (:IMA) has a price-to-earnings ratio of -1.45 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED